BR8807151A - Processos para aumentar a adenosina extracelular e para estabilizar celulas"masto" - Google Patents

Processos para aumentar a adenosina extracelular e para estabilizar celulas"masto"

Info

Publication number
BR8807151A
BR8807151A BR888807151A BR8807151A BR8807151A BR 8807151 A BR8807151 A BR 8807151A BR 888807151 A BR888807151 A BR 888807151A BR 8807151 A BR8807151 A BR 8807151A BR 8807151 A BR8807151 A BR 8807151A
Authority
BR
Brazil
Prior art keywords
masto
stabilize
cells
processes
extracellular adenosine
Prior art date
Application number
BR888807151A
Other languages
English (en)
Inventor
Harry Edward Gruber
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of BR8807151A publication Critical patent/BR8807151A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Re-Forming, After-Treatment, Cutting And Transporting Of Glass Products (AREA)
  • Discharge Heating (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Examining Or Testing Airtightness (AREA)
BR888807151A 1987-07-29 1988-07-29 Processos para aumentar a adenosina extracelular e para estabilizar celulas"masto" BR8807151A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/079,657 US4912092A (en) 1986-03-27 1987-07-29 Methods for increasing extracellular adenosine and for stabilizing mast cells
PCT/US1988/002527 WO1989000854A1 (en) 1987-07-29 1988-07-29 Methods for increasing extracellular adenosine and for stabilizing mast cells

Publications (1)

Publication Number Publication Date
BR8807151A true BR8807151A (pt) 1989-10-17

Family

ID=22151963

Family Applications (1)

Application Number Title Priority Date Filing Date
BR888807151A BR8807151A (pt) 1987-07-29 1988-07-29 Processos para aumentar a adenosina extracelular e para estabilizar celulas"masto"

Country Status (13)

Country Link
US (1) US4912092A (pt)
EP (2) EP0301900B1 (pt)
JP (1) JPH02500916A (pt)
AT (1) ATE135580T1 (pt)
AU (3) AU2315088A (pt)
BR (1) BR8807151A (pt)
CA (1) CA1335716C (pt)
DE (1) DE3855120T2 (pt)
DK (1) DK175978B1 (pt)
ES (1) ES2087061T3 (pt)
FI (1) FI891463A0 (pt)
GR (1) GR3019389T3 (pt)
WO (1) WO1989000854A1 (pt)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597683B1 (fr) * 1986-04-22 1992-07-31 Battarel Claude Clavier a interrruption de rayonnement.
US5082829A (en) * 1989-01-24 1992-01-21 Gensia Pharmaceuticals AICA riboside prodrugs
DK0427799T3 (da) * 1989-01-24 1995-05-08 Gensia Inc Fremgangsmåde og forbindelser til indgivelse af AICA-ribosid og til nedsættelse af blodglucose
US5658889A (en) * 1989-01-24 1997-08-19 Gensia Pharmaceuticals, Inc. Method and compounds for aica riboside delivery and for lowering blood glucose
AU643235B2 (en) * 1989-09-15 1993-11-11 Gensia Pharmaceuticals, Inc. Methods of treating neurodegenerative conditions
US5366440A (en) * 1989-10-06 1994-11-22 The Beth Israel Hospital Association Methods for treating disease states using oxidized lipoproteins in conjunction with chemotherapeutic effector agents
US5192264A (en) * 1989-10-06 1993-03-09 The Beth Israel Hospital Association Methods and apparatus for treating disease states using oxidized lipoproteins
US6180616B1 (en) 1990-05-10 2001-01-30 Atsuo F. Fukunaga Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function
US6004945A (en) 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US5777100A (en) * 1990-08-10 1998-07-07 Gensia Inc. AICA riboside analogs
IL99125A0 (en) * 1990-08-10 1992-07-15 Gensia Pharma Derivatives of imidazole analog of aica riboside and their use
IL99124A (en) * 1990-08-10 1998-02-22 Gensia Pharma Substituted imidazole analogs of aica riboside
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
WO1992012718A1 (en) * 1991-01-23 1992-08-06 Gensia, Inc. Adenosine kinase inhibitors
US5236908A (en) * 1991-06-07 1993-08-17 Gensia Pharmaceuticals, Inc. Methods of treating injury to the central nervous system
WO1993003734A1 (en) * 1991-08-23 1993-03-04 Gensia, Inc. Method for lowering blood lipid levels
IL103294A0 (en) * 1991-09-30 1993-05-13 Gensia Pharma Pharmaceutical compositions for preventing tissue damage associated with decreased blood flow
IL108522A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Pharmaceutical compositions containing adenosine deaminase inhibitors, for preventing or treating thrombosis ischemia and inflammatory conditions, especially sepsis
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
WO1995001097A1 (en) * 1993-06-30 1995-01-12 Board Of Regents, The University Of Texas System Nucleotide preparation and uses thereof in wound healing
US6342484B1 (en) 1993-06-30 2002-01-29 Board Of Regents, The University Of Texas Systems Method and compositions for promotion of wound treatment
US5366960A (en) * 1993-08-26 1994-11-22 Warner-Lambert Company Method of treating cerebral and cardiovascular disorders employing [R]3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz 0-[4,5-d][1,3]diazepin-8-ol
US5859017A (en) * 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5780450A (en) * 1995-11-21 1998-07-14 Alcon Laboratories, Inc. Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage
EP1174141A3 (en) * 1996-01-23 2003-04-23 ICN Pharmaceuticals, Inc. Modulation of TH1/TH2 cytokine expression by ribavirin and ribavirin analogs in activated t-lymphocytes
US6187542B1 (en) * 1996-10-03 2001-02-13 The Trustees Of The University Of Pennsylvania Methods for the identification of patients at risk for heart failure
EP1044002A4 (en) 1997-11-07 2003-05-02 Univ Johns Hopkins METHODS FOR THE TREATMENT OF HEART CONTRACTILITY
US6800616B2 (en) 1998-02-26 2004-10-05 Supergen, Inc. Treatment of HIV infections
US6174873B1 (en) 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs
AU2026900A (en) * 1998-11-20 2000-06-13 Salk Institute For Biological Studies, The Neuron stimulation by ribavirin, and analogs thereof
US6680292B1 (en) 1998-11-20 2004-01-20 The Salk Institute For Biological Studies Pharmaceutical composition comprising ribavirin and growth factors and methods of use
US6579857B1 (en) * 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
US6300328B1 (en) 1999-08-06 2001-10-09 Alcon Universal Ltd. Selective inhibitors of adenosine monophosphate deaminase for the treatment of optic nerve and retinal damage
WO2001010449A1 (en) * 1999-08-09 2001-02-15 Trustees Of Boston University Method of maintaining vascular integrity using aicar (5-amino-4-imidazole riboside) and related compounds
MXPA02005959A (es) * 1999-12-16 2003-10-14 Alcon Inc Inhibidores de adenosina cinasa para el tratamiento del nervio optico y el bano retiniano.
US20030166568A1 (en) * 2000-03-23 2003-09-04 Franz Kricek Organic compounds
US20020086835A1 (en) * 2000-05-22 2002-07-04 Law William R. Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
AU2001268236A1 (en) * 2000-06-06 2001-12-17 Trustees Of Boston University Use of aicar and related compounds
WO2001097816A1 (en) * 2000-06-16 2001-12-27 Brigham Young University Use of amp kinase activators for treatment of type 2 diabetes and insulin resistance
US20030212034A1 (en) * 2001-06-11 2003-11-13 Winder William W Method of treatment of obesity and paralyzed muscle and ergogenic aids
US20030212013A1 (en) * 2001-06-14 2003-11-13 Winder William W Use of amp kinase activators for treatment type 2 diabetes and insulin resistance
ES2192495B1 (es) * 2002-03-21 2005-02-16 Universidad De Barcelona Nuevo uso terapeutico del ribosido de 5-aminoimidazol-4-carboxamida (acadesina).
JP2006517807A (ja) * 2002-12-30 2006-08-03 パーデュー・リサーチ・ファウンデーション 中枢神経系の損傷の治療方法
US20060079479A1 (en) * 2004-10-13 2006-04-13 Italo Biaggioni Methods of inducing vasodilation
US7687473B2 (en) * 2005-01-07 2010-03-30 Health Research, Inc. 5-amino-4-imidazolecarboxamide riboside and its nucleobase as potentiators of antifolate transport and metabolism
EP1863497A4 (en) * 2005-03-28 2009-08-12 Pericor Therapeutics Inc METHODS, COMPOSITIONS, AND FORMULATIONS FOR PREVENTING OR REDUCING ADVERSE EFFECTS IN PATIENTS
WO2007017505A2 (en) * 2005-08-09 2007-02-15 Cellzome Ag Treatment of metabolic diseases
WO2007017512A1 (en) * 2005-08-09 2007-02-15 Cellzome Ag Treatment of inflammatory diseases
US20070082859A1 (en) * 2005-10-07 2007-04-12 Stover Richard R Formulations of AICA riboside
US7811549B2 (en) * 2006-07-05 2010-10-12 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
WO2008086341A1 (en) * 2007-01-09 2008-07-17 Pericor Therapeutics, Inc. Methods. compositions, and formulations for preventing or reducing adverse effects in a patient
US20090185973A1 (en) * 2008-01-22 2009-07-23 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
EP2349284B1 (en) * 2008-10-03 2016-11-23 Pericor Therapeutics, Inc. Treatment of acute decompensated heart failure
US20100261666A1 (en) * 2009-04-14 2010-10-14 The Board Of Trustees Of The University Of Illinois Compositions and methods for the treatment of myocardial dysfunction associated with sirs or sepsis
CA2778647A1 (en) * 2009-11-25 2011-06-03 Nestec S.A. Nutritional compositions including a high protein component and exogenous nucleotides
US8895520B2 (en) 2011-10-26 2014-11-25 Universite Nice Sophia Antipolis Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide
US20150031712A1 (en) 2013-03-12 2015-01-29 Moshe Rogosnitzky Therapeutic Compositions Containing Dipyridamole and Treatment Packs Including Such Compositions and Methods for Producing Same
AU2016298794A1 (en) 2015-06-08 2018-02-01 O.D. Ocular Discovery Ltd. Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions, and methods for producing same
CA3107170A1 (en) * 2018-08-06 2020-03-12 Skylark Bioscience Llc Amp-activated protein kinase activating compounds and uses thereof
US11779590B2 (en) 2020-10-30 2023-10-10 Skylark Bioscience Llc AMP-activated protein kinase activating compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
AU529532B2 (en) * 1978-09-18 1983-06-09 Commonwealth Scientific And Industrial Research Organisation Frequency response analyser
AU529815B2 (en) * 1981-05-15 1983-06-23 Fisons Plc Optically active imidazole derivatives
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
WO1987005807A1 (en) * 1986-03-27 1987-10-08 Harry Edward Gruber A method of increasing adenosine excretion

Also Published As

Publication number Publication date
FI891463A (fi) 1989-03-28
JPH02500916A (ja) 1990-03-29
DE3855120D1 (de) 1996-04-25
EP0301900A3 (en) 1989-09-20
EP0672418A2 (en) 1995-09-20
DK148889D0 (da) 1989-03-28
EP0672418A3 (en) 1996-05-29
AU2315088A (en) 1989-03-01
DK175978B1 (da) 2005-10-17
CA1335716C (en) 1995-05-30
DK148889A (da) 1989-05-29
EP0301900A2 (en) 1989-02-01
ES2087061T3 (es) 1996-07-16
FI891463A0 (fi) 1989-03-28
EP0301900B1 (en) 1996-03-20
WO1989000854A1 (en) 1989-02-09
US4912092A (en) 1990-03-27
AU687112B2 (en) 1998-02-19
AU8039394A (en) 1995-03-09
GR3019389T3 (en) 1996-06-30
DE3855120T2 (de) 1996-09-19
AU1285592A (en) 1992-06-04
ATE135580T1 (de) 1996-04-15

Similar Documents

Publication Publication Date Title
BR8807151A (pt) Processos para aumentar a adenosina extracelular e para estabilizar celulas"masto"
FI861340A0 (fi) Engaongsbloejor med enhetligt midjeskydd och elastiskt taenjbara midjeband.
FI873492A (fi) Dipyridamol eller mopidamol och o-acetylsalicylsyra eller deras fysiologiskt uthaerdbara salter innehaollande laekemedelspreparats framstaellningsfoerfarande och deras anvaendning foer att foerhindra trombosbildning.
EP0151989A3 (en) Means for the treatment of cardiac diseases
DK313984A (da) Urinindlaeg til engangsbrug
ATE48082T1 (de) Wegwerfdamenbinde in flexibler schale.
ATE69548T1 (de) Vitamin e-haltiges mittel zur verbesserung der eigenschaften des blutes.
SE8505047L (sv) Fettemulsion
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
IT1116032B (it) Composizione e procedimento per la determinazione della concentrazione del glucosio in fluidi corporei
ES2052614T3 (es) Uso de factor xiii de coagulacion de la sangre humana para el tratamiento de la colitis ulcerosa.
ES557404A0 (es) Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
DE3764697D1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
ATE40795T1 (de) Verwendung eines zerebral und peripher wirkenden antihypoxidotikums.
DE3889549D1 (de) Verfahren zur Steigerung des Phosphatidylcholins in Vivo.

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/70 (2006.01), A61K 31/7056 (2006.0